Primary endpoint analysis
| Endpoint | Frequency |
| Safety endpoints | |
| Device-related vessel perforation or dissection requiring clinical intervention | 0 (0%) |
| Device-related vessel thrombosis or occlusion | 0 (0%) |
| Device-related vasospasm with permanent neurological manifestation | 0 (0%) |
| Device malfunction resulting in permanent neurologic injury or death | 0 (0%) |
| Effectiveness endpoints | |
| Navigation through the neurovasculature | 25/25 (100%) |
| Contrast delivered successfully as intended | 7/7 (100%) |
| Intended therapy delivered successfully with Bendit | 14/18 (77.8%) |